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Abstract.  NOP1 is an essential nucleolar protein in 
yeast that is associated with small nucleolar RNA and 
required for ribosome biogenesis. We have cloned the 
human nucleolar protein,  fibriUarin,  from a HeLa 
cDNA library.  Human fibrillarin  is 70%  identical to 
yeast NOP1 and is also the functional homologue 
since either human or Xenopus fibrillarin can comple- 
ment a yeast nopl- mutant.  Human fibrillarin  is local- 
ized in the yeast nucleolus and associates with yeast 
small nucleolar RNAs. This shows that the signals 
within eucaryotic fibrillarin required for nucleolar as- 
sociation and nucleolar function are conserved from 
yeast to man.  However, human fibrillarin only par- 
tially complements in yeast resulting in a temperature- 
sensitive growth,  concomitantly altered rRNA process- 
ing and aberrant nuclear morphology. A  suppressor of 
the human fibrillarin ts-mutant was isolated and found 
to map intragenically at a single amino acid position 
of the human nucleolar protein.  The growth rate of 
yeast nopl- strains expressing Xenopus or human 
fibrillarin or the human fibrillarin  suppressor corre- 
lates closely with their ability to efficiently and cor- 
rectly process pre-rRNA.  These findings demonstrate 
for the first time that vertebrate fibrillarin  functions in 
ribosomal RNA processing in vivo. 
T 
HE nucleolus is the site of transcription  of the rRNA 
genes, processing of precursors to cytoplasmic rRNA 
molecules, and assembly of ribosomal particles (for 
review see Hadjiolov,  1985; Scheer and Benavente,  1990). 
The mechanisms underlying  these processes are largely un- 
known,  but some of these biochemical pathways have been 
localized to specific subnucleolar compartments identified by 
immunocytochemical and electron microscopy approaches. 
The transcription  of the rRNA genes by RNA-polymerase I 
takes place in the fibrillar  centers (FC) t of the nucleolus, 
the subsequent preribosome formation  in the dense fibrillar 
component (DFC) surrounding  the fibrillar centers.  Further 
assembly and maturation  steps of the preribosomal particles 
finally occur outside the FC-region in the granular  compart- 
ment  (GC)  (for review  see Hadjiolov,  1985;  Scheer  and 
Benavente,  1990). 
It is assumed that this complex structural organization  of 
the nucleolus is a requirement for the coordinate assembly 
of ribosomes (for review see Hadjiolov,  1985).  Compara- 
tively little is known about the role of nucleolar proteins  in 
ribosome biogenesis.  Several nucleolar proteins have been 
identified (for review see Nigg, 1988; Scheer and Benavente, 
1990) which have been localized to the different subnucleo- 
lar compartments.  Among these nucleolar proteins a 34-36- 
kD protein called fibrillarin,  because of its location to the 
DFC, appears to be one key component in ribosomal biogen- 
esis. Fibrillarin  was initially identified in Physarum (Chris- 
tensen et al.,  1977) and later in mammalian  ceils with the 
help of autoimmune  sera from patients  with scleroderma 
(Ochs et al.,  1985). 
Anti-fibrillarin  antibodies  precipitate RNPs that  contain 
the small nucleolar RNAs (snoRNA) U3, US, and U13 (Tyc 
and Steitz,  1989). This physical association between fibrilla- 
rin and snoRNAs implied a role of the protein in processing 
of rRNA precursors within the dense fibrillar component and 
direct evidence for this recently came from an in vitro pro- 
cessing  system using antibodies against  fibrillarin  (Kass et 
al.,  1990). In the budding yeast Saccharomyces cerevisiae, 
a 38-kD nucleolar protein named NOP1 has been identified 
that is immunologically  related to vertebrate fibrillarin (Aris 
and Blobel, 1988; Hurt et al., 1988; Schimmang et al., 1989). 
NOP1 has been cloned and sequenced (Schimmang  et al., 
1989; Henriquez et al.,  1990) and its glycine/arginine-rich 
amino-terminal  domain was shown to have sequence homol- 
ogy to other nucleolar proteins,  such as yeast SSB1 (Jong et 
al.,  1987), nucleolin  (Lapeyre et al.,  1987), as well as rat 
fibrillarin (Lischwe et al., 1985). Yeast NOP1 is an abundant 
nucleolar protein that is essential for growth (Schimmang et 
al., 1989) and required  for the modification and processing 
of pre-rRNA (Tollervey et al., 1991), suggesting that it may 
be one of the key components in nucleolar structure and func- 
tion. Furthermore, NOP1 is associated with snoRNAs impli- 
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U3, snRl0, snR190, and U14 (previously snR128) (Zagorski 
et al., 1988; Tollervey, 1987; Li et al., 1990). Xenopus fibril- 
larin has also been cloned (Lapeyre et al.,  1990)  and, as 
deduced from the DNA-sequence, its amino acid sequence 
is highly homologous to yeast NOP1  (Schimmang et al., 
1989). These data suggested that yeast NOP1 and vertebrate 
fibrillaxin may perform a conserved function in the eucaryotic 
nucleolus. 
To analyze the general role of eucaryotic fibrillarin for nu- 
cleolar structure and ribosome biogenesis, we have isolated 
from a HeLa eDNA library the gene coding for human fibril- 
larin. When expressed in yeast, human fibrillarin comple- 
ments a yeast mutant defective in NOP1. This shows that the 
basic function of fibrillarin is conserved from yeast to man. 
Materials and Methods 
Growth of Yeast Strains and Microbiological Methods 
The diploid yeast strain JU4-2xJR26-19B (a/a, ade2-1/ade2d,  ade8/ADES, 
canl-100/canl-100, his4/HIS4, his3/HIS3,  leu2-3/leu2-3,  lysl-1/lysl-1, ura3- 
52/urn3-52) and the diploid transformant TF38NULL heterozygous for the 
NOP1  alleles (a/a,  ade2-1/ade2-1, ade8/ADES,  can 1-100/canl-100, his4/ 
HIS4,  his3/HIS3,  leu2-3/leu2-3,  lysl-1/lysl-1, ura3-52/URA3,  nopl/NOP1) 
were used.  Strains were grown in rich glucose-containing medium (YPD- 
medium) or minimal glucose-containing  medium with the appropriate  nu- 
trients as described earlier (Schimmang et al., 1989). Yeast transformation 
was done by the lithium acetate method (Sherman et al.,  1986). Diploid 
yeast  strains were  sporulated on YPA plates (1% yeast extract,  2% bac- 
topeptone, 1% potassium acetate, 2% agar); 3 d later, sporulated asci were 
treated with cytohelicase  and then dissected to isolate  four tetrad spores 
which were germinated and grown on YPD plates at 23°C. 
Gene Disruption 
One copy of the NOP1 gene was completely evicted from the diploid strain 
JU4-2xJR26-19B according to Rothstein  (1983). The genomic NOP1 gene 
located on a 2.5-kb EcoRI restriction fragment (see also, Schimmang et al., 
1989) was inserted into the single EcoRI restriction site of plasmid pUC19. 
It was cut with restriction enzymes EcoRV and SnabI, which released from 
the plasmid the complete coding region of the NOP1 gene. A 1.1-kb blunt- 
ended HindIII restriction fragment containing the URA3 gene was inserted 
into this plasmid thereby attaching to the URA3 gene 5' and 3' noncoding 
sequences of the NOP1 gene. This construct composed of the URA3-gene 
plus adjacent 5' and 3' noncoding NOP1 DNA was excised from the plasmid 
by EcoRI and ,,o10 #g of this linear DNA fragment was used to transform 
the diploid  yeast strain JU4-2xJR26-19B.  URA  + transformants  were ob- 
tained which carded the NOPI gene disruption at the homologous locus as 
demonstrated by Southern analysis (data not shown). One of these transfor- 
mants (TF38NULL) heterozygous for NOP1 was transformed with the hu- 
man fibrillarin gene present on a 2# yeast plasmid and tetrad analysis was 
performed. 
Recombinant DNA Work, Southern and Northern 
Analysis, Immunoprecipitation, and Isolation of the 
Human Hbrillarin cDNA by PCR 
DNA recombinant work was performed as outlined by Maniatis et al. (1982). 
DNA restriction fragments were purified from agarose gels using the "Gene 
Clean" kit (Biol01, La Jolla, CA). Southern and Northern analysis was per- 
formed under high stringency conditions as described by Schimmang et al. 
(1989). Immunoprecipitation was performed as described by Schimmang et 
al. (1989).  A HeLa eDNA library inserted into plasmid pUEX1  (kindly 
provided by Dr. G. Banting, Bristol, England) was used to clone the human 
fibrillarin gene.  The eDNA library present in Escherichia  coli was am- 
plified in liquid L-Broth medium containing 25 #g/ml ampicillin at 30°C. 
Plasmid DNA was isolated and used for PCR amplification  of the human 
fibrillarin gene. Oligonucleotide  primers corresponding to 5'- and 3" con- 
served regions of the yeast NOP1 (Schimmang  et al.,  1989) and Xenopus 
fibrillarin (Lapeyre et al.,  1990)  were designed according to Moreman 
(1989). The forward and reverse primer which correspond to cytosine-610 
and thymidine-1084 of the NOP1 gene (see also, Schimmang et al.,  1989) 
Were: 
5'-CCIGGIGAG/AIIIGTITAC/~__d3IGAA/G  AAG-3' 
5'-A/GTCIATA/oCAA/GTTIGCT/c TTIAT-3'. 
A typical  PCR amplification  assay contained in a 50-#1 reaction volume: 
50 mM KC1, 1.5 mM MgC12, 10 mM Tris,  pH 8.3, 0.05%  gelatine,  0.2 
mM dNTPs,  10% DMSO,  75 pM forward and backward  primers (corre- 
sponding to the 5' and 3' part of the NOP1 gene), 50 ng plasmid DNA with 
inserted HeLa eDNA and 2.5 U Taq-polymerase from Perkin-Elmer Corp. 
(Norwalk,  CT). The samples were placed in an automated heating/cooling 
block which was programmed for a temperature step cycle of 94°C (1 rain), 
50°C (2 rain), and 72°C (2 rain). 30 cycles were run and the products were 
then analyzed by 1.5% agarose gel electrophoresis.  The amplified band of 
expected size (470 nucleotides)  was isolated,  labeled with 32p-dCTP using 
the "multi-prime DNA  labeling" kit from Amersham Corp.  (Arlington 
Heights, IL) and a full-length eDNA clone of human fibrillarin was isolated 
from the same eDNA library in pUEXl by colony hybridization under high 
stringency conditions (Gruenstein and Hogness,  1975; see also Schimmang 
et al., 1989). Double-stranded dideoxy sequencing of the alkaline denatured 
cDNA probe (a total length of 1,090 nucleotides) from plasmid pUEXl was 
performed for both strands (Sanger et al.,  1977). 
Construction of the Human HbriUarin Gene under 
the Alcohol Dehydrogenase Promoter 
The cloned human fibrillarin eDNA present in plasmid pUEX1 contains in 
the 5' noncoding region an extra ATG-eodon which is not in frame with the 
long open reading frame of human fibrillarin (see also Fig.  1 A). To max- 
imize expression in yeast, this upstream ATG was removed by digesting the 
cDNA with restriction enzyme BanII which cuts four nucleotides upstream 
of the fibriUarin ATG-start eodon (see also Fig.  1 A). A blunt-ended BanII 
restriction fragment containing the entire human fibrillarin gene was then 
inserted into the blunt-ended  restriction site EcoRI of plasmid pBPHI which 
comained 5' to this EcoRI site the alcohol dehydrogenase  I (ADHI) pro- 
moter (see also Hurt et al., 1985). pBPHI is a YCpS0 derivative which car- 
ries the ADHI-promnter (McKnight and MeConanghy,  1983) and a pUC19- 
polylinker with multiple cloning sites downstream of the promoter. 
From this constructed plasmid, the human fibrillarin gene under ADHI 
promoter control was excised as a  1.7-kb EcoRV/HindIII  restriction frag- 
ment and inserted into the 2# yeast plasmid YEP13 which had been previ- 
ously cut with restriction enzymes PvuII/HindIIL YEP13  contains as a 
selectable marker the LEU2 gene (Broach et al.,  1979). Plasmid YEP13- 
ADHI-humFib was then used to transform the diploid  strain TF38NULL 
heterozygous for the NOP1 allele (see above). LEU+/URA+-transformants 
were sporulated and haploid progeny containing the evicted NOP1 gene and 
plasmid YEP13-ADHI-humFib  were further characterized.  For control, the 
human fibrillarin gene was inserted also in opposite orientation  downstream 
of the ADH-promoter to block its expression in yeast.  Furthermore, the 
authentic NOP1 gene (a genomic 2.5-kb EcoRI restriction fragment)  was 
inserted into the ARS/CEN plasmid pSB32 (kindly provided by R. Serrano, 
EMBL, Heidelberg)  and introduced in TF38NULL by transformation and 
selection for LEU  + transformants.  Haploid progeny carrying the disrupted 
genomic NOP1 gene and plasmid pSB32-NOP1  or YEPI3-ADHI-humFib 
were compared. 
To obtain the expression of Xenopus fibrillarin in Saccharomyces cere- 
visiae, the eDNA from pXomfib (Lapeyre  et al.,  1990) was cloned as a 
SalI-BamHI fragment into the SalI-BamHI sites of YEpS1 (Broach et al., 
1983) to generate pXenfib. The vector contains the 2# origin of replication 
and the LEU2 gene, permitting its replication  and selection in yeast.  The 
promoter region of the GALl0 gene is located  5' to the SalI cloning site; 
transcription of the inserted cDNA is therefore  induced during growth on 
galactose  medium and strongly  repressed  by growth  in the presence of 
glucose. 
Isolation of Human 15"brillarin ts-Suppressors 
A haploid yeast strain carrying the disrupted genomie NOP1 gene and plas- 
mid YEP13-ADHI-humFib  (called A2), which is temperature-sensitive  for 
growth at elevated temperatures, was plated on YPD-plates and incubated 
at 37°C  for 5 d.  Spontaneous suppressors  arose which after purification 
showed efficient growth at 30°C and still could grow at the restrictive tem- 
perature of 35°C.  Plasmid DNA was recovered from these suppressors  by 
isolation of total DNA (Sherman et al.,  1986) followed by transformation 
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I0  30  50 
GGATCCGGCAACGAAGGTACCATGGCCGGACTCCGGAGCCGCACAAACCAGGGCTCGCCA 
M 
70  90  110 
TGAAGCCAGGATTCAGTCCCCGTGGGGGTGGCTTTGGCGGCCGAGGGGGCTTTGGTGACC 
K  P  G  F  S  P  R  G  G  G  F  G  G  R  G  G  F  G  D  R 
130  150  170 
GTGGTGGTCGTGGAGGCCGAGGGGGCTTTGGCGGGGGCCGAGGTCGAGGCGGAGGCTTTA 
G  G  R  G  G  R  G  G  F  G  G  G  R  G  R  G  G  G  F  R 
190  210  230 
GAGGT  CGTGGACGAGGAGGAGGTGGAGGCGGCGGCGGCGGTGGAGGAGGAGGAAGAGGT  G 
G  R  G  R  G  G  G  G  G  G  G  G  G  G  G  G  G  R  G  G 
250  270  290 
GTGGAGGCTTCCATT  CTGGTGGCAACCGGGGTCGTGGTC  GGGGAGGAAAAAGA  GGAAAC  C 
G  G  F  H  S  G  G  N  R  G  R  G  R  G  G  K  R  G  N  Q 
310  330  350 
AGTCGGGGAAGAATGTGATGGTGGAGCCGCATCGGCATGAGGGTGTCTTCATTTGTCGAG 
S  G  K  N  V  M  V  E  P  H  R  H  E  G  V  F  I  C  R  G 
370  390  410 
GAAAGGAAGATGCACTGGTCACCAAGAACCTGGTCCCTGGGGAATCAGTTTATGGAGAGA 
K  E  D  A  L  V  T  K  N  L  V  P  G  E  S  V  Y  G  E  K 
430  450  470 
AGAGAGTCT CGAT  TTCGGAAGGAGATGACAAAATTGAGTACCGAGCC  TGGAAC  C  C  CTTC  C 
R  V  S  I  S  E  G  D  D  K  I  E  Y  R  A  W  N  P  F  R 
490  510  530 
G  CTCCAAGCTAGCAGCAGCAATCCTGGGTGGTGTGGACCAGATCCACAT  CAAACCGG GGG 
S  K  L  A  A  A  I  L  G  G  V  D  Q  I  H  I  K  P  G  A 
550  570  590 
CTAAGGTTCTCTACCTCGGGGCTGCCTCGGGCACCACGGTCTCCCATGTCTCTGACATCG 
K  V  L  Y  L  G  A  A  S  G  T  T  V  S  H  V  S  D  I  V 
610  630  650 
TTGGTCCGGATGGTCTAGTCTATGCAGTCGAGTTCTCCCACCGCTCTGGCCGTGACCTCA 
G  P  D  G  L  V  Y  A  V  E  F  S  H  R  S  G  R  D  L  I 
670  690  710 
TTAACTTGGCCAAGAAGAGGACCAACATCAT  TCCTGT  GATCGAGGATGCTCGACACCCAC 
N  L  A  K  K  R  T  N  I  I  P  V  I  E  D  A  R  H  P  H 
730  750  770 
ACA~TACCGCATGCTCATCGCAATGGTGGATGTGATCTTTGCTGATGTGGCCCAGCCAG 
K  Y  R  M  L  I  A  M  V  D  V  I  F  A  D  V  A  Q  P  D 
790  810  830 
ACCAGACCCGGATTGTGGCCCTGAATGCCCACACCTTCCTGCGTAATGGAGGACACTTTG 
Q  T  R  I  V  A  L  N  A  H  T  F  L  R  N  G  G  H  F  V 
S50  870  890 
TGATTTCCATTAAGGCCAACTGCATTGACTCCACAGCCTCAGCCGAGGCCGTGTTTGCCT 
I  S  I  K  A  N  C  I  D  S  T  A  S  A  E  A  V  F  A  S 
910  930  950 
CCGAAGT GAAAAAGATGCAACAGGAGAAC  AT  GAAGCC  GC  AGGAGCAGTT GAC  CCT  TGAGC 
E  V  K  K  M  Q  Q  E  N  M  K  P  Q  E  Q  L  T  L  E  P 
990  990  1010 
CATATGA~GAGACCAT  GCCGTGGTCGTGGGAGTGTACAGGCCAC  C  C  CCCAAGGTGAAGA 
¥  E  R  D  H  A  V  V  V  G  V  Y  R  P  P  P  K  V  K  N 
1030  1050  1070 
ACTGAAGTTCAGCGCTGTCAGGATTGCGAGAGATGTGTGTTGATACCATGGTACCTTCGT 
1090 
TGCCGGATCC 
8HUMrIB 
NOPI 
XENFIB 
MKPGFSPRGG--GF--GGRGGFGDRGGRGGRGGF-GGGRGRGGGFRGRGRGGGGGGGGG- 
M--SFRP-GSRGGSRGGSRGGFGGRGG--SRGGARGGSR---GGFGGRG-GSRGGARGGS 
MRPGFSPRGGRGGF--GDRGGFGGRGGFGDRGGFRGGSRG---GFGGRGRGGDRGGRGGF 
*  .**  *.  *  *.*****.***  ***  ***  **  ***  *.  *.  ** 
HUMFIB 
NOPI 
XENFIB 
-GGGGRGGGGFHSGGNRGRGRGGKRGNQSGK  .... NVMVEPHRHEGVFICRGKEDALVTK 
RGGFG--GRGGS~GGARGGSRGGRGGAAGGARGGAKWlKPMRHAGVYIARGKEDLLVTK 
RGGFSSPGRGGPRGGGRGGFGGGRGGFGAGR  ....  KVIVEPHRHEGIFICRGKEDALVTK 
**  *  *  .**.**  **  *  .*  .*..*****.*..*  *****  **** 
HUMFIB 
NOPI 
XENFIB 
NLVPGESVYGEKRVSISEGD  .......  DKIEYRAWNPFRSKLAAAILGGVDQIHIKPGAK 
NMAPGESVYGEKRISVEEPSKEDGVPPTKVEYRVWNPFRSKLAAGIMGGLDELFIAPGKK 
NLVPGESVYGEKRISVEDGE  .......  VKTEYRAWNPFRSKIAAAILGGVDQIHIKPGVK 
*..*******~**.*  ....  *  ***********************  *  **  * 
HUMFIB 
NOPI 
XENFIB 
VLYLGAASGTTVSHVSDIVGPDGLVYAVEFSHRSGRDLINLAKKRTNIIPVIEDARHPHK 
VLYLGAASGTSVSHVSDVVGPEGVVYAVEFSHRPGRELISMAKKRPNIIPIIEDARHPQK 
VLYLGAASGTTVSHVSDVVGPEGLVYAVEFSHRSGRDLINVAKKRTNIIPVIEDARHPHK 
************************************************************ 
HUMFIB  YRMLIAMVDV IFADVAQP DQTRIVALNAHTFLRNGGHFV  I  S  IKANC  IDSTASAEAVFASE 
NOPI  YRML  I  GMVDCVFADVAQP DQAR  I  I  ALNSHMFLKDQGGW  I  S  I  KANC  I  DSTVDAE  TVFARE 
XENFIB  YRI  LVGMVDVVFADVAQPDNTR  IVALNAHNFLKNGGHFVIS  IKANC  IDSTAAPEAVFAAE 
Q 
HUMFIB  VKKMQQENMKP QEQ  LTLEP  YE  RDHAVVVGVYRPPPKVKN 
NOPI  VQKLREER I  KPLEQLTLEP YERDHC  IVVGRYMRSG-LKK 
XENFIB  VKKMQQENMKPQEQLT LE  P  YERD  HAVVVG  I  YRP  P  PKQKK 
*.*..  *.  **  ***-********  ***  *...  *. 
*  :=>  match  across  all  seqs. 
•  :=>  conservative  substitutions 
Figure 1.  Human  fibrillarin and yeast NOP1  are highly  homolo- 
gous. (A) Sequence analysis of the human fibrillarin cDNA.  Clon- 
ing and sequencing of the human fibrillarin cDNA is described in 
Materials and Methods.  The Nil-length cDNA clone with a length 
of 1,090 nucleotides contains a long open reading frame preceded 
by an A'll3-start cedon ceding  for a  protein of 321  amino  acids. 
These  sequence  data  are  available  from  EMBL/GenBank/DDBJ 
under accession number 56597. (B) Amino acid sequence compari- 
of E. coil and selection for ampicillin-resistant  clones. Reisolated  plasmids 
YEP13-ADHI-humFib  were used to transform a haploid yeast strain whose 
authentic NOPI gene was replaced by a modified NOP1 gene under the con- 
trol of the regulatory GALl0 promoter (Tollervey et al., 1991). If grow.n on 
glucose, this strain was completely dependent on the functional  expression 
of the  human  fibrillarin.  Reisolated  plasmids YEPI3-ADHI-humFib that 
supported growth at 35°C in the GAL10-NOPI strain were assumed to con- 
tain an intragenic  mutation  suppressing  the temperature-sensitive  growth. 
Accordingly,  the DNA sequence of the coding region of these human fibril- 
larin genes was determined  by the dideoxy sequencing method (Sanger et 
al.,  1977). 
Pulse-Chase Labeling of rRNA 
For pulse-chase labeling of pre-rRNA, 3 ml of cells growing in glucose min- 
imal medium  at OD600 '~0.3,  were labeled with  100 #Ci of either  [3H- 
methyl]methionine  or [3H]uracil for 2 rain at 30°C. Unlabeled methionine 
was added to a final concentration  of 5 raM,  unlabeled  uracil  was added 
to a final concentration  of 240 #g/ml-L Samples  (1 mi) were taken,  trans- 
ferred to 1.5-ml centrifuge  tubes at room temperature and centrifuged  for 
8 s at full speed in an Eppendorf 5414 centrifuge  (Brinkman Instruments 
Co.,  Westbury, NY) at room temperature.  Cell pellets were immediately 
frozen in a dry ice/ethanol bath and stored at -80°C until used. The time 
for harvesting and freezing of the cells (1 min) is included in the chase times. 
RNA extraction,  agarose/formaldehyde  gels, gel transfer and fluorography 
were as previously described (Tollervey,  1987). 
Yeast Indirect Immunofluorescence 
and Confocal Microscopy 
Indirect immunofluorescence  on yeast ceils complemented by human fibril- 
larin was done essentially as previously described (Schimmang et al., 1989). 
Double indirect immunofluorescence  was done using affinity-purified anti- 
NSP1  antibodies  (anti-rabbit)  and a  monoclonal  antibody  against  yeast 
NOP1  and cross-reactive  with human  fibrillarin  (anti-mouse;  rnAb A66, 
kindly provided by Dr. J. Avis, Rockefeller  University,  New York) followed 
by second antibodies,  Texas red goat anti-rabbit and fluorescein goat anti- 
mouse lgGs, diluted 1:50. Cells stained for NSP1 and NOP1 were inspected 
in the confoeal microscope developed at the EMBL (Stelzer et al.,  1989). 
HeLa Cell Culture, Fractionation, 
and Immunocytochemistry 
Suspension HeLa cells ($3) were grown to a density of 1-4 ×  105 cells/mi 
in Joklik's  modified minimum essential medium supplemented  with 5% 
newborn  calf serum and containing  penicillin and streptomycin. 
Nuclei were prepared  according  to Ohtsubo et al. (1989).  Briefly,  the 
cells were homogenized with a Dounce homogenizer in ice-cold hypotonic 
buffer (10 mM Hepes, pH 8.0, 5 mM KCI, 2 mM MgCI2) containing  0.5% 
NP-40 and  1 mM PMSE  Nuclei were pelleted at 1,000 g  for 5  min. 
Immunofluorescence  microscopy  was performed  using isolated HeLa 
nuclei attached  to poly-L-lysine-coated  glass coverslips.  The nuclei were 
fixed in 3.7% paraformaldehyde and sequentially  incubated with anti-human 
fibrillarin  affinity-purified  antibodies  (diluted  1:10)  and  Texas  red-con- 
jugated goat anti-rabbit lgG (diluted  1:I00).  Immunofluorescence  was car- 
fled out with a Zeiss Axiophot Photomicroscope. 
Monolayer cultures  of HeLa cells were grown in minimum essential 
medium supplemented  with 10% fetal calf serum and nonessential amino 
acids and containing penicillin and streptomycin.  The cells were fixed with 
8% paraformaldehyde  in 200 mM Hepes (pH Z4), prepared for cryosec- 
tioning  and  labeled  with  antibodies  and  protein  A-gold  as  described 
(Hurt et al.,  1988). 
son between human and Xenopus fibrillarin and yeast NOP1.  The 
amino acid sequence of yeast NOP1  (middle sequence,  NOP1),  of 
human fibrillarin (top sequence,  HUMFIB),  and Xenopus fibrilla- 
rin (bottom sequence, XENFIB) were compared by computer anal- 
ysis. Identical and structurally related amino acids are marked. The 
amino acid (K ~  Q) altered in the temperature resistant mutant ob- 
tained  for human  fibrillarin  is indicated above the  HUMFIB  se- 
quence. 
Jansen et al. Human Fibrillarin Expression in Yeast  717 Figure 2. Human fibrillarin  can complement a yeast mutant lacking the NOP1 gene, but are temperature sensitive for growth. Transforma- 
tion of TF38NULL heterozygous for NOP1 with plasmid YEP13-ADHI-humFib  and tetrad analysis of such a transformant was done as 
described in Materials  and Methods.  (Top) Four tetrad spores (1-4)  were germinated and then grown on YPD plates at 23"C (5 d) and 
37°C (3 d). 1 and 2, haploid progeny containing genomic NOP1 and plasmid YEP13-ADHI-httmFib  (ura3-/LEU2+); 3 and 4, haploid 
progeny with evicted genomic NOP1 gene and plasmid YEP13-ADHI-humFib  (URA3+/LEU2+). Strains 3 and 4 are temperature sensitive 
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Lane 1,  yeast  cell  extract  from the nopl- yeast 
strain complemented by cloned NOP1; lane 2, yeast 
cell extract from the nopl- strain complemented 
by human fibrillarin (YEP13-ADHI-humFib). Im- 
munoblots were prepared from total cell extracts. 
Three identical immunoblots were decorated with 
S4-antoimmune serum (left), anti-human fibrilla- 
tin affinity-purified antibodies (center), and an im- 
mune serum made ~inst isolated, SDS-denatured 
yeast NOP1 (right). The position of  NOPI and hu- 
man fibrillaxin is indicated by arrows and molecu- 
lax mass markers (in kilodaltons) are shown. The 
migration  difference between  NOP1 and  human 
fibrillaxin is due to a difference in molecular mass. 
A protein band of '~ 30 kD is weakly cross-reac- 
tive with anti-human fibrillarin antibodies in a to: 
tal yeast homogenate (center, lane I), but this pro- 
tein is nonnuclear  and exclusively found in the 
post-nuclear  supematant (data not shown). 
Propidium Iodide Staining of Yeast Cells 
and Confocal Microscopy 
Haploid yeast cells with evicted NOP1 gene and complemented  by YEP13- 
ADHI-humFib were grown in YPD medium to OD~00 ,x,0.5 at 23°C. Half 
of  the culture was shifted for 15 h to 37°C. Cells from a 20-ml culture grown 
at 23°C and 370C  were harvested by centrifugation, washed in PBS and 
fixed in 1 ml ethanol for 30 min at 0°C. Cells were centrifuged, washed in 
PBS, and incubated in 1 ml of 1 mg/ml RNAse A for 90 rain at 37°C. After 
a wash in PBS, cells were stained in a volume of 0.3 ml PBS with 50 #g/ml 
propidium iodide for 20 min at 0°C. Cells were finally washed twice in PBS, 
mounted in 80%  glycerol on a coverslip and inspected in the fluorescence 
confocal microscope developed at the EMBL (Stelzer et al.,  1989). 
Generation of  Anti-FtbriUarin Peptide Antibodies 
A peptide corresponding to the carboxy-terminal end of human fibrillarin 
(YERDHAVVVGVYRPPPKVKN) was coupled to hemocyanin using glu- 
taraldehyde as cross-linker  and injected into rabbits. Antibodies against hu- 
man fibrillarin were affinity-purified  from this immune serum using a fusion 
protein between E. coli/3-galactosidase  and human fibrillarin expressed in 
E.  coli as an affinity ligand. 
Computer Analysis 
The DNA sequence of  human fibrillarin eDNA and its predicted amino acid 
sequence was analyzed by the programs of the University of Wisconsin 
Genetics Computer Group (UWGCG). The mol wt and amino acid compo- 
sition was obtained by PEPTIDESORT. The amino acid sequence compari- 
son between yeast NOPI and human fibrillarin was done using the program 
BESTFIT. 
Miscellaneous 
Preparation of  total protein extracts from yeast cells, SDS-PAGE, immuno- 
blotting, affinity purification of  antibodies, subcellular fractionation of  yeast 
cells, and purification of yeast nuclei was done as described by Schimmang 
et al.  (1989). 
Results 
Human FibriUarin Is 70% Identical to Yeast NOP1 
We have isolated the gene coding for the human homologue 
of NOP1  and tested its in vivo function in Saccharomyces 
cerevisiae, which is amenable to genetic manipulation.  By 
PCR using oligonucleotides corresponding to the 5' and 3' 
regions  of the yeast NOP1  gene,  a  DNA-fragment of 470 
nucleotides was amplified from a HeLa eDNA library. This 
was  subsequently  used  to  isolate  the  putative  full-length 
eDNA clone (1,090 nucleotides) by colony hybridization. On 
Northern blots,  the isolated eDNA predominantly hybrid- 
ized to a human polyA  + RNA species of ,,o1.1 kb, 'but no hy- 
bridization was detectable to yeast RNA (data not shown). 
The  DNA  sequence  of the  full-length  HeLa eDNA clone 
contains a  single open reading frame, potentially encoding 
a protein of 321 residues corresponding to 34 ED (Fig. 1 A). 
The calculated isoelectric point of 10.98  points to a  basic 
protein. A salient feature of the open reading frame is a gly- 
cine/arginine-rich sequence at the amino terminus found also 
in several other nucleolar proteins. 
Comparison of yeast NOP1 with the deduced amino acid 
of the cloned human gene and Xenopus fibriUarin (Lapeyre 
et al., 1990) shows that yeast NOP1 and human fibrillarin are 
70 % identical and 80 % similar if conserved amino acid ex- 
changes are also included, while NOP1 and Xenopus fibrilla- 
rin are 72%  identical and 83%  similar (Fig.  1 B).  Human 
and Xenopus fibrillarin are 81%  identical. 
Human FibriUarin Can Complement a Yeast Mutant 
Lacking the Nucleolar Protein NOPI 
The high degree of structural similarity between NOP1 and 
for growth at 37°C. (Bottom) Haploid nopl- yeasts complemented by human fibrillarin (YEP13-ADHI-humFib) were grown at 23 or 37°C 
for 15 h and inspected in the light microscope.  Cells grown at 23°C reveal normal cell morphology, in contrast to cells arrested at 37°C 
that have increased  cell size and daughter  cells show long bud projections. 
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calized to the nucleolus and  associated with small 
nucleolar RNA. (A) Indirect immunofluorescence mi- 
croscopy using affinity-purified  anti-human fibrillarin 
antibodies. The yeast strain lacking the genomic NOP1 
gene and complemented by human fibrillarin was grown 
at 23°C in YPD-medium, fixed in 3 % formaldehyde, 
and processed for immunofluorescence microscopy. 
The immunostaining using affinity-purified anti-fibril- 
latin antibodies (left) and DNA staining using 5/zg/ 
ml Hoechst 33258 (right) is shown. Cells with a cres- 
cent-shaped nucleolar staining are indicated by arrows. 
(B) Immunoprecipitation of  yeast small nucleolar RNAs 
from yeast strains expressing human fibrillarin. Lane 
1, total RNA from a NOP1 + strain grown at 25°C; 
lane 2, RNA immunoprecipitated  from a NOP1  + strain 
grown at 25°C with nonimmune human serum; lane 3, 
RNA immunoprecipitated from a NOP1 + strain grown 
at  25°C  with affinity-purified anti-NOP1  antibody; 
lane 4, total RNA from a nopl- strain expressing hu- 
man fibrillarin and grown at 25°C; lane 5, RNA im- 
munoprecipitated from a nopl- strain expressing hu- 
man fibrillarin and grown at 25°C with nonimmune 
human serum; lane 6, RNA iramunoprecipitated  from 
a nopl- strain expressing human fibrillarin and grown 
at 25°C  with affinity-purified anti-NOP1  antibody; 
lane 7, total RNA from a nopl- strain expressing hu- 
man fibrillarin and grown at 36°C; lane 8, RNA im- 
munoprecipitated from a nopl- strain expressing hu- 
man fibriUarin and grown at 36°C with nonimmune 
human serum; lane 9, RNA immunoprecipitated  from 
a nopl- strain eXl~ressing  human fibrillarin and grown 
at 36°C with affinity-purified anti-NOPl antibody (de- 
rived from immune serum ECI-1). After immunopre- 
cipitation, RNA was recovered and analyzed  by North- 
ern hybridization using probes to the snoRNAs U3, 
snR10, snRl90,  snR128,  and the snRNA U6. human or Xenopus fibrillarin suggested that these proteins 
may be functionally  equivalent. To test this, the human fibril- 
larin gene was placed under the control of the constitutively 
active alcohol dehydrogenase I (ADHI) promoter on a 2/~ 
yeast plasmid. In the absence of a  functional NOP1  gene, 
haploid strains of yeast are not viable (Schimmang et al., 
1989). To rescue the mutant, the plasmid carrying the human 
fibrillarin gene was introduced into a diploid strain of yeast, 
heterozygous for nopl: :URA3 (one NOP1 allele has been de- 
stroyed by gene replacement).  Diploid transformants con- 
taining the plasmid were  sporulated and asci with tetrad 
spores were dissected. From strains expressing human fibril- 
larin, all four tetrad spores could be recovered (4:0 segrega- 
tion)  and two of them  always contained both  the  URA3 
marker (indicative of the disrupted NOP1  gene) as well as 
the plasmid carrying the human fibriUarin gene (Fig. 2, top, 
23°C). From strains transformed with the same vector lack- 
ing the human fibrillatin cDNA, or with the cDNA inserted 
downstream of  the ADHI promoter but in the opposite orien- 
tation,  a  2:2  segregation  for  viability  was  found.  This 
demonstrates that human fibriUarin is functional in yeast and 
can complement an otherwise nonviable yeast mutant lack- 
ing authentic NOP1. 
To obtain the expression of Xenopus fibrillarin in Sac- 
charomyces cerevisiae, the cDNA (Lapeyre et al., 1990) was 
cloned under the control of the GALl0 promoter in YEp51 
(Broach et al., 1983) to generate pXenFib. Transcription of 
the inserted cDNA is induced during growth on galactose 
medium and strongly repressed by growth in the presence of 
glucose. To test the ability of Xenopus fibrillarin to function 
in yeast, pXenFib was transformed into a diploid strain in 
which  one  chromosomal copy  of NOP1  is  destroyed by 
replacement with a disrupted nopl: :URA3 allele. When the 
diploid  transformed with  pXenFib  is  sporulated  and  the 
spores germinated on galactose medium, four viable spores 
can be  recovered  from  tetrads,  with 2:2  segregation for 
NOP1 ÷ and nopl::URA3. Spore outgrowth on glucose me- 
dium results in 2:2 segregation of viability and, as with the 
parent diploid (Schimmang et al.,  1989),  the nopl::URA3 
marker is not recovered.  Haploids shown genetically to carry 
nopl: :URA3 and pXenFib are able to grow on galactose but 
not glucose medium (data not shown), showing them to be 
dependent on expression of Xenopus fibrillarin. 
Synthesis of human fibrillarin in yeast was demonstrated 
by immunoblotting (Fig. 3). An autoimmune serum contain- 
ing  anti-human  fibrillarin  antibodies  (serum  $4;  kindly 
provided by Dr. R. Liihrmann, Marburg, FRG) reacted on 
immunoblots with proteins corresponding to the expected 
position of yeast NOP1 and human fibrillarin, but additional 
bands were also observed (Fig. 3, left). Specific antibodies 
were generated by raising an immune serum against a pep- 
tide  present  in  the  less  well-conserved  carboxy-terminal 
region of human fibrillarin (see also  Fig.  1 B).  Affinity- 
purified antibodies derived from this serum reacted on im- 
munoblots with human fibrillarin expressed in yeast, but not 
with authentic NOP1 (Fig. 3, center). Conversely, antibodies 
raised  against purified,  SDS-denatured  yeast NOP1  only 
weakly cross-reacted with human fibrillatin (Fig. 3, righO. 
These  experiments  show  that  the  complemented haploid 
strains contain human fibrillarin but do not contain NOP1. 
Human l~briUarin Expressed in Yeast 
Is Localized to the Nucleolus and Can Associate 
with Small Nucleolar RNA 
To locate the human protein in yeast, subcellular fraction- 
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ation of yeast cells  expressing  HeLa fibrillarin was  per- 
formed. A crude nuclear pellet was applied on a sucrose gra- 
dient to separate nuclei from other organelles (see also, Hurt 
et al.,  1988).  Human fibrillarin cofractionated on this gra- 
dient within histone H2B and was mostly recovered in frac- 
tion IV containing the purified nuclei (data not shown). 
The nuclear location of human fibrillarin in yeast was 
confirmed by indirect immunofluorescence  microscopy using 
affinity-purified anti-fibrillarin antibodies (Fig.  4  A).  The 
immunolabeling was mostly restricted to the nucleus, but did 
not exactly colocalize with the DNA staining. Frequently, 
the immunolabeling was crescent shaped (Fig. 4 A, arrows) 
which is typical for the appearance of the yeast nucleolus in 
the light microscope (see also, Sillevis Smitt et al.,  1973; 
Hurt et al.,  1988). 
The anti-peptide antibody against the cloned human fibril- 
latin also recognizes a single band *36 kD on immunoblots 
containing a total HeLa cell extract (data not shown). The 
electrophoretic mobility on SDS-PAGE of  the HeLa cell pro- 
tein is identical to that of human fibrillarin expressed  in 
yeast. Furthermore, immunocytochemistry using the anti- 
fibrillarin peptide antibody showed specific labeling of the 
nucleolar DFC  region on HeLa cells and isolated nuclei 
(data not shown). This observation is consistent with previ- 
ous data describing fibrillarin as a nucleolar protein strictly 
located at the DFC. 
To determine whether human fibrillarin can associate in 
vivo with yeast snoRNAs, the pattern of immunoprecipita- 
tion was compared from lysates of cells expressing NOP1 or 
human fibrillarin.  Anti-NOP1  antibodies  that cross-react 
with human fibrillarin (Aris and Blobel, 1989;  Schimmang 
et al., 1989) immunoprecipitate yeast snoRNAs with differ- 
ing efficiencies (Fig. 4 B; see also, Schimmang et al., 1989); 
snR10 and snR190 are more efficiently precipitated than U3 
and snR128.  From the strain expressing human fibrillarin, 
snR10,  snR128  and  U3  are  immunoprecipitated by  anti- 
NOP1  antibodies with an  efficiency similar to that from 
NOP1 + strains (see also, Schimmang et al.,  1989),  while 
snR190 is precipitated with slightly reduced efficiency. The 
non-nucleolar snRNA U6 is not immunoprecipitated by anti- 
NOP1 antibodies (Fig. 4 B). The immunoprecipitation of  the 
snoRNAs is very likely to be due to the presence of human 
fibrillarin in the yeast snoRNPs. We have placed NOP1 un- 
der  the  control  of an  inducible  promoter;  from  strains 
depleted of NOP1 these snoRNAs are very weakly immuno- 
precipitated by anti-NOP1 antibodies (Tollervey et al., 1991). 
An antibody directed against a peptide present in the less 
well-conserved carboxy-terminal region of human fibtiUa- 
fin, gives a weak precipitation of U3,  snRl0, snR190,  and 
snR128  from the strain expressing human fibrillarin (data 
not shown). The carboxy terminus of human fibtillatin may 
be not exposed and thus be less accessible for immunopre- 
cipitation. The impaired growth of strains expressing human 
fibrillarin (see below) is probably not due to defective inter- 
actions with the snoRNAs, since immunoprecipitation with 
anti-NOP1 antibodies is equally efficient from lysates of  cells 
grown at 25 or 36°C (Fig. 4 B). 
Yeast Cells Dependent on Human Fibrillarin Are 
Temperature Sensitive for Growth and Arrest at 37°C 
with an Aberrant Nuclear Morphology 
Complementation by the human NOPl-homologue is  not 
complete, perhaps due to a less efficient  interaction of  human 
fibrillarin with the corresponding  nucleolar structures  in 
yeast. At 23°C the doubling time for growth in liquid me- 
721 Figure 5.  Yeast ceils comple- 
mented  by  human  fibrillarin 
arrest at 37°C  with aberrant 
nuclear morphology. Expres- 
sion of human fibrillarin in a 
yeast nopl- mutant at 23  and 
37°C, nuclear staining of cells 
with propidium iodide, confo- 
cal  microscopy,  indirect im- 
munofluoreseenee  and electron 
microscopy is described in Ma- 
terials and Methods. (A) Con- 
focal microscopy of propidium 
iodide stained nuclei of nopl- 
cells expressing human fibril- 
larin and arrested for 15 h at 
37°C (upper panel) and indi- 
rect immunofluoreseenee mi- 
croscopy using affinity-purified 
anti-NOPl antibodies (bottom). 
In many cells, irregular DNA- 
staining and  multinucleate struc- 
tures  are observed,  The  cell 
boundary is indicated in the 
top panel. In the bottom pan- 
el, the immunofluoreseenee sig- 
nal was superimposed with the 
light  microscopic picture  in 
order to visualize both nuclei 
and the eel boundary. (B) Anti- 
NSPI/anti-NOP1 double immu- 
nofluoreseenee using affinity- 
purified anti-NSP1  antibodies 
and  a  monoclonal  antibody 
against  yeast  NOP1  (kindly 
provided  by Dr. J. Aris, Rocke- 
feller University, New  York) 
cross-reactive with human fi- 
brillarin followed by confocal 
microscopy. A yeast cell com- 
plemented by human fibrilla- 
rin  and  arrested  at  37°C  is 
shown.  Two  nuclear  rings 
(NSP1 staining) are evident in 
this single cell, but only one 
nucleus reveals fibrillarin stain- 
ing. (C) Electron microscopy 
of fixed and Epon-embedded 
cells.  Yeast  cells with  a  de- 
fective  genomic  NOP1  gene 
and expressing either authen- 
tic NOP1 on a plasmid (NOP1) 
or human fibrillarin (humFib) 
were shifted for 15 h to 37°C 
before fixation and embedding. 
Control ceils (NOP1) contain 
a single nucleus, whereas mu- 
tant cells (humFib) often re- 
veal more than  one nucleus. 
Nuclei are marked (N). 
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human fibriUarin. (A) Growth of a nopl:: 
URA3 strain expressing human fibriUarin 
(humFib) or a derived intragenic suppressor 
of human fibrillarin (SHFII) on YPD me- 
dium at 23 and 35°C for 4 d.  (B) Amino 
acid  sequence comparison  between yeast 
NOP1 and human fibrillarin in the region 
where intragenic reversion of the human fi- 
brillarin occurred. Lysine  (284) was changed 
into a glutamine (see also Fig.  1 B). 
dium is ~6 h for strains expressing only human fibrillarin, 
as compared to ~2 h for control cells (see also Fig. 2, top, 
23°C). This growth rate difference is even more prominent 
at elevated temperatures. At 37°C, yeast cells expressing the 
human fibrillarin completely stop cell growth within 10-15 
h (Fig. 2, top) and arrest with a strikingly aberrant cell mor- 
phology (Fig. 2, bottom).  Unbudded cells were in general 
larger than normal. When daughter cells were still attached 
to mother cells, they carried long bud projections. Intracel- 
lularly, the nucleus was irregularly shaped in arrested cells 
and propidium iodide staining frequently revealed more than 
one nucleus in the enlarged unbudded cells (Fig. 5 A, top). 
By indirect immunofluorescence using anti-NOP1 antibod- 
ies, two clearly separated nucleoli can often be seen in a sin- 
gle arrested cell (Fig. 5 A, bottom). If mutant cells are stained 
with antibodies against NSP1, a nuclear envelope protein lo- 
cated at the nuclear pores (Nehrbass et al., 1990), frequently 
two individual rings corresponding to the nuclear periphery 
of two individual nuclei are seen (Fig. 5 B). By performing 
double indirect immunofluorescence using anti-NSPl  and 
anti-NOP1  antibodies, we see with a  significant frequency 
that only one of the two nuclei in a single cell contains the 
nucleolar antigen suggesting that the correct segregation of 
the nucleolus in mother and daughter nucleus may be further 
affected in these mutant cells (Fig. 5 B). Cells grown at room 
temperature contain a  single nucleus which is distinct and 
round-shaped (data not shown). Cells expressing both NOP1 
and human fibrillarin do not show an abnormal morphology. 
On  the  ultrastructural  level,  strains  expressing  human 
fibrillarin and arrested at 37°C revealed altered nuclear mor- 
The Journal of Cell Biology,  Volume 113, 1991  724 Figure 7. Pulse-chase labeling of pre-rRNA with [3H]uracil. (A)NOP1  ÷ strain, (B) nopl: :URA3 strain complemented by human fibrilla- 
rin, grown at 25°C, (C) nopl::URA3 strain complemented by human fibriUarin, grown for 5 h at 36°C, (D) nopl::URA 3 strain com- 
plemented by human fibrillarin containing the suppressor mutation, grown at 25 °C, (E) nopl::URA3 strain complemented by human fibril- 
larin containing the suppressor mutation, grown at 36°C, (F) nopl::URA3 strain complemented by Xenopus fibriUarin. Pre-rRNA was 
pulse labeled with [3H]uracil for 2.5 min at 25 or 36°C and chased with a large excess of unlabeled uracil for 1, 2.5, or 5 min as indi- 
cated. After gel separation, RNAs were transferred to Genescreen + membrane and visualized by fluorography. The positions of 25S and 
18S rRNAs and 35S, 32S, 27SA, 27SB, 23S, 22S, and 20S pre-rRNAs are indicated. 
phology and enlarged cells often had more than one nucleus 
(Fig. 5  C).  These nuclei were surrounded by a continuous 
nuclear membrane (Fig. 5 C, right). In comparison, control 
ceils expressing authentic NOP1  and grown at 37°C  con- 
tained a  single nucleus (Fig. 5 C, left). 
Cells  complemented by Xenopus fibrillarin  grow better 
than cells complemented by human fibrillarin. At 25°C in 
YPGal medium the doubling times are 2.8 h for NOP1 ÷ ceils 
and 3.5 h for nopl: :URA3 cells complemented by Xenopus 
fibrillarin. At 300C the doubling times are 2.2 h for NOP1 ÷ 
and 3 h  for the complemented strain.  At 36°C the relative 
growth rate of the complemented strain is reduced (doubling 
times are 2.2 h  for NOP1 ÷ and 5  h  for the complemented 
strain).  Therefore the strain complemented by Xenopus fi- 
briUarin does not show the tight TS lethality of yeasts com- 
plemented by human fibrillarin. However, Xenopus fibrilla- 
rin was expressed in yeast using the strong GALl0 promoter, 
whereas human fibrillarin was under the control of the less 
strong ADHI promoter. Interestingly, if Xenopus fibrillarin 
is expressed in a nopl- strain using the ADHI promoter, it 
still can complement the mutant at the permissive tempera- 
ture (i.e., 23°C), but not at 37°C. Expression levels of both 
human  and Xenopus fibriUarin using  the ADHI promoter 
were similar in yeast as shown by immunoblot analysis (Jan- 
sen, R., unpublished results).  Thus, TS lethality of yeast cells 
complemented by Xenopus fibrillarin depends on the level of 
fibrillarin expression. We have not checked whether the same 
is true for human fibrillarin, but by completely derepressing 
the ADHI promoter (growth on a  nonfermentable carbon 
source) yeast cells are still temperature sensitive for growth 
(data not shown). 
A Critical Amino Acid Residue within Human 
~brillarin Possibly Involved in Interaction with Yeast 
Nucleolar Components 
The tight TS-lethal phenotype of nopl::URA3 strains com- 
plemented by human fibrillarin enabled us to select for sup- 
pressor mutations which allow this strain to grow at the non- 
permissive temperature. Among these, intragenic mutations 
within the human fibrillarin gene were found to be able to 
rescue the complemented strain at the restrictive tempera- 
ture (Fig. 6 A). When the suppressor human fibrillarin gene 
(SHF II) was sequenced, only 1 bp within the entire coding 
region was changed (Fig. 6 B). As deduced from the DNA 
sequence, a single amino acid was altered: lysine (284) to 
glutamine. The amino acid change has the consequence that 
the suppressor human fibrillarin becomes more similar to 
yeast NOP1. 
Jansen et al. Human Fibrillarin Expression in  Yeast  725 Figure 8. Pulse-chase labeling of pre-rRNA with [3H-methyl]methionine.  (A) NOP1  +  strain, (B) nopl: :URA3 strain complemented by hu- 
man fibrillarin, grown at 25°C, (C) nopl::URA3  strain complemented by human fibrillarin, grown for 5 h at 36°C, (D) nopl::URA3 
strain complemented by human fibdllarin containing the suppressor mutation, grown at 25°C, (E) nopl::URA3 strain complemented by 
human fibrillarin containing the suppressor mutation, grown at 36°C, (F) nopl: :URA3 strain complemented by Xenopus fibrillafin. Pre- 
rRNA was pulse labeled with [3H-methyl]methionine  for 2.5 min at 25 or 36°C and chased with a large excess of unlabeled methionine 
for 1, 2.5, or 5 min as indicated. After gel separation, RNAs were transferred to Genescreen+  membrane and visualized by fluorography. 
The positions of 25S and 18S rRNAs and 35S, 32S, 27SA, 27SB, 23S, 22S, and 20S pre-rRNAs are indicated. 
Processing of  pre-rRNA in nopl: :  URA3 Strains 
Complemented by Xenopus or Human FibriUarin 
To test the ability of human and Xenopus fibrillarin to sup- 
port pre-rRNA processing in yeast, pulse-chase labeling ex- 
periments were performed using [3H]uracil  or [3H-methyl]- 
methionine (Figs. 7 and 8). For both isotopes, labeling was 
for 2.5 min at 25°C, with 1-, 2.5-, or 5.5-min chase. These 
two isotopes show different aspects of pre-rRNA processing. 
[3H]Uracil labeling  shows  the fate of the RNA backbone, 
[3H-methyl]methionine labels the methyl groups which are 
added to newly synthesized pre-rRNAs,  generally in 35S, 
and shows the degree of methylation of the pre-rRNA.  In 
NOP1 ÷ strains  (Figs.  7  A and 8 A)  the processing of 35S 
pre-rRNA is very rapid, and even after 1 min of chase most 
has been processed to 27SA and 20S pre-rRNA,  and after 
5.5-rain chase almost all has been matured to 25S and 18S 
rRNA. 
In nopl::URA3 strains complemented by human fibrilla- 
rin, the processing of 35S RNA is greatly slowed, even at 
25°C (Figs. 7 B and 8 B). The 32S and 27SA pre-rRNAs are 
absent and 20S pre-rRNA is greatly reduced, and the pro- 
cessing of 27SB is also slowed. 18S rRNA is synthesized in 
lower yield than 25S  rRNA.  At 36°C,  processing of pre- 
rRNA is even more severely impaired (Figs. 7  C and 8 C). 
The most striking effect is the loss of detectable synthesis of 
18S rRNA, and the immediate precursor to 18S rRNA, 20S 
pre-rRNA, is also absent. A faint band below 18S is visible 
in Figs. 7 C and 8 C; this is also visible in other samples and 
does not comigrate with 18S rRNA. The processing of 35S 
and 27SB pre-rRNAs is substantially slowed, 32S and 27SA 
are not detected and a 23S species accumulates strongly. Ma- 
ture 25S rRNA is labeled by [3H-methly]methionine, even 
in the earliest time point (Fig. 8 B), indicating that methyl 
groups which in the wild type are added to 35S RNA, are 
added to later processing products, perhaps 25S rRNA it- 
self, in the human fibrillarin complemented strain.  More- 
over, 35S and 23S pre-rRNA which accumulate at 36°C are 
detected by uracil labeling but not by labeling with methio- 
nine (compare Fig.  7  C with 8 C),  indicating that the un- 
processed pre-rRNAs are not methylated. The accumulation 
of uumethylated pre-rRNAs is also observed in strains de- 
pleted of NOP1  (Tollervey et al.,  1991). 
In strains complemented by human fibrillarin containing 
the suppressor mutation, processing of  pre-rRNA is dramat- 
ically improved. At 250C the efficiency of processing is re- 
stored to a  level close to that of NOP1 ÷ strains (compare 
Fig. 7, B with D and Fig. 8, B with D), although some delay 
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rin (under GALl0 promoter control) (Figs. 7 F and 8 F), the 
processing of  pre-rRNA is less defective than in strains com- 
plemented by human fibrillarin, but is detectably impaired. 
The processing of 35S pre-rRNA is slowed and the levels of 
32S and 27SA are reduced, although both are detected. 18S 
rRNA clearly accumulates in the 5-min chase sample al- 
though a number of abnormal pre-rRNA species are visible 
between 25S and 18S rRNA. Depletion of Xenopus fibrilla- 
rin by repression of the GAL promoter during growth in 
glucose minimal medium for 30 h results in a block in pre- 
rRNA processing closely resembling that seen in strains de- 
pleted of yeast NOP1 by glucose repression of a GAL: :nopl 
control mutant (data not shown) (Tollervey et al.,  1991). 
The  steady-state levels  of the  18S  and  25S  ribosomal 
RNAs were compared for nopl- strains complemented by 
human fibrillarin at 25°C or following growth for 5 h at 35°C 
(Fig. 9, lanes 2 and 3), by the suppressor human fibriUarin 
(Fig. 9, lane 4) or by Xenopus fibrillarin (Fig. 9, lane 5). 
Comparison to the NOP1 + strain (Fig. 9, lane 1) or a nopl- 
strain carrying the NOP1 gene on a high copy number plas- 
mid (Fig. 9, lane 6) shows that those strains complemented 
by vertebrate fibrillarins all have a similar, significantly re- 
duced level of 18S rRNA. 
Figure 9.  Steady-state levels of ribosomal RNA in nopl- strains 
complemented by vertebrate fibrillarins. Lane 1,  NOP1  + strain; 
lane 2, nopl- strain complemented by human fibrillarin grown at 
25°C;  lane 3,  nopl- strain complemented by human fibrillarin 
grown at 36°C; lane 4, hop1- strain complemented by suppressor 
human fibrillarin; lane 5, nopl- strain complemented by Xenopus 
fibrillarin grown at 25°C; lane 6, nopl- strain complemented by 
NOP1 + on a high copy number plasmid. Where not stated, cells 
were grown at 300C. RNA equivalent to 107 cells was separated 
by electrophoresis on an agarose/formaldehyde  gel and is visualized 
by ethidium staining. 
in processing of 35S pre-rRNA is detected. At 36°C, pro- 
cessing is less efficient (Figs. 7 E and 8 E), although much 
better than in strains complemented by the wild-type human 
fibrillarin (compare Fig. 7, C with E and Fig. 8, C with E). 
As well as restoring efficient processing of pre-rRNA,  the 
human fibrillarin mutation also reduces the aberrant methyl- 
ation observed in strains complemented by wild-type human 
fibrillarin (compare Figs. 8, B and D  with 8,  C and E). 
Discussion 
Recently, an essential nucleolar protein,  NOP1,  has been 
cloned in yeast, which is  related to  vertebrate  fibriUarin 
(Schimmang et al., 1989; Henriquez et al., 1990).  To study 
the  conserved  role  of eucaryotic fibrillarin for  nucleolar 
structure and function in an organism that is amenable to 
genetic  approaches,  we  cloned the  human homologue of 
NOP1, fibrillarin, and obtained its functional expression in 
yeast. On the amino acid level, yeast NOP1 and human fibril- 
larin are 70% identical and 80 % similar if conserved amino 
acids exchanges are included. This high degree of conserva- 
tion is only found in a few eucaryotic "house keeping" pro- 
teins such as ubiquitin (96%),  actin (89%),  and/~-tubulin 
(75%),  which play key roles  in universal eucaryotic cell 
functions (Botstein and Fink,  1988).  A  salient feature of 
NOP1 and fibrillarin is an amino-terminal sequence of "~80 
amino acids, consisting of a repeated motif rich in glycines 
and arginines, which is also found in other nucleolar pro- 
teins such as nucleolin (Lapeyre et al., 1987) and yeast SSB1 
(Jong et al., 1987). In fibrillarin, this sequence is posttrans- 
lationally modified by dimethylation of arginine  residues 
(Christensen et al., 1977; Lischwe et al., 1985). The role of 
the glycine/arginine-rich  repeat domain in nucleolar proteins 
is not clear, but its conservation in evolution and presence 
in several different nucleolar proteins argues for an impor- 
tant function. 
The high degree of structural conservation of eucaryotic 
fibrillarin is matched by functional interchangeability. Fi- 
brillarin from human (or Xenopus), despite more than 1,000 
million years of  evolution, can still functionally  replace yeast 
NOP1. This demonstrates that the basic role of fibrillarin is 
identical from yeast to man and that the human protein can 
interact with the cognate nucleolar components  in yeast. 
Consistent with this,  human fibriUarin  can bind to  yeast 
snoRNAs and is correctly localized to the nucleolus. Corn- 
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plete,  however,  at 25"C the growth of the complemented 
strain is about three times slower than that of the wild type, 
and at 36°C cell growth stops. A human protein is unlikely 
to be destabilized at 36°C, and this suggests that vertebrate 
fibrillarin interacts less strongly with yeast components than 
does authentic NOP1. Consistent with this, high level expres- 
sion ofXenopus fibrillarin from the strong GALl0 promoter 
on a multicopy plasmid suppresses the "IS lethality. Thus TS 
lethality also depends on the expression level  of the ver- 
tebrate fibrillarin. 
The temperature-sensitive phenotype of the yeast mutant 
expressing human fibrillarin was exploited to isolate sup- 
pressor mutations. In this way we hope to obtain a detailed 
genetic analysis of the functionally important domains of 
fibrillarin 0ntragenic suppression) and the molecules with 
which it interacts (extragenlc suppression). An initial intra- 
genie suppressor mutation of the human fibrillarin which 
allows growth at the restrictive temperature has been charac- 
terized. The alteration of a single amino acid in the carboxy- 
terminal part of human fibrillarin to the corresponding amino 
acid within the NO/I protein is sufficient for suppression at 
35°C. This amino acid and the region surrounding it, may 
be critical for interaction with other nucleolar components; 
alternatively the changed amino acid residue may cause a 
conformational change within the suppressor human fibrilla- 
rin sufficient for complementation at elevated temperatures. 
In Xenopus fibrillarin a lysine residue is found at the corre- 
sponding amino acid position (see Fig. 1 B). Xenopus  fibril- 
larin does not complement at 35°C if expressed in similar 
quantities as compared to human fibriUarin  (under the con- 
trol of the ADH promoter), but allows slow growth at ele- 
vated temperatures if strongly overexpressed with the help 
of the GALl0 promoter. The further biochemical, immuno- 
logical, and genetic characterization of this region in human 
fibrillarin and NO/I thus could allow us to identify further 
components of the eucaryotic nucleolus involved in ribo- 
some biogenesis. 
Concomitant with the growth arrest at 37°C, nuclear mor- 
phology is changed in the strain expressing human fibrillarin 
and many cells have two nuclei. Frequently, only one nucleus 
in such cells contains the nucleolar antigen. The aberrant nu- 
clear and nucleolar organization might reflect ongoing nu- 
clear division, without a block in segregation into mother 
and daughter cells. This indicates that fibrillarin may play an 
important role in organizing nucleolar structure and, as a 
consequence, the overall nuclear structure. It is interesting 
to note that a  nonrandom positioning of the spindle pole 
body and the nucleolus has been found in yeast (Yang et al., 
1989),  both  structures being  associated with the  nuclear 
membrane and preferentially localized at opposite poles of 
the nucleus. This suggests the existence of communication 
between these structures that may be lost in the mutant cells 
with distorted nucleolar structure. As a  consequence, nu- 
clear division, nuclear, and/or nucleolar segregation could 
be  impaired.  In  yeast,  the  nucleolus is  continuously as- 
sociated with the nuclear envelope during mitosis spanning 
in a  highly elongated form mother and daughter nucleus 
(Ads and Blobel, 1988; E. Hurt, unpublished results). Thus, 
the nucleolus could further provide a structural axis inside 
the nucleus along which correct nuclear division and segre- 
gation proceeds. 
How could alterations in fibrillarin affect both nucleolar 
structure and function? As shown for human fibrillarin and 
yeast NO/I, both proteins are in physical interaction with 
different small nucleolar RNAs (Tyc and Steitz, 1989; Schim- 
mang et al., 1989). Because of this interaction, a role in pro- 
cessing of  precursor ribosomal RNA has been presumed and 
indeed had been recently demonstrated in vitro (Kass et al., 
1990).  Fibrillarin, however, may also have a structural role 
in organizing the dense fibrillar component and thereby pro- 
viding the appropriate  structural support for correct and 
efficient ribosomal RNA processing. Our data on altered nu- 
clear structure in yeast ceils expressing human fibriUarin 
support such a role. 
Pulse-chase labeling of pre-rRNA indicates that the im- 
paired growth of  nopl-deleted yeast strains complemented by 
human or Xenopus fibrillarin is likely to be due to defective 
pre-rRNA  processing.  The  strain  complemented by high 
level expression of Xenopus fibrillarin at 25°C has a growth 
rate that is not greatly slower than NO/I  + strains, and is 
only mildly impaired in pre-rRNA processing. In the strain 
complemented by human fibrillarin, processing is substan- 
tially impaired at either 25 or 36°C, however, at 25°C a re- 
duced but clearly detectable level of 18S rRNA is synthe- 
sized, whereas, at 36°C no 18S rRNA synthesis is detected. 
The inability of this strain to synthesize 18S  rRNA may 
therefore be the direct cause of the TS-lethality.  At 25°C the 
human fibrillarin suppressor mutation restores growth, and 
the efficiency of pre-rRNA processing, comes close to that 
of NOP1 + strains. Examination of the steady-state levels of 
rRNA in the strains complemented by Xenopus fibrillarin, 
human fibrillarin or the suppressor human fibrillarin, shows 
that all of these strains have a reduced level of 18S rRNA, 
corresponding to "~30%  of the level in NO/I + strains.  It 
appears that there is a minimum, but fairly high level of 18S 
which  is  either  required  for growth or maintained by a 
regulatory system. There are obvious reasons why a  cell 
which is unable to synthesize ribosomes for whatever reason 
should not let its ribosome pool fall to low levels, since such 
a position would be irrecoverable if ribosome synthesis then 
became possible again. Ribosomes are needed to make new 
r-proteins and there is essentially no free r-protein pool. The 
high growth rate of yeast means that most ribosome synthe- 
sis goes simply to replace ribosomes lost by dilution. The 
growth rate of the mutants therefore declines until the rate 
of 18S synthesis of which they are capable allows them to 
maintain this "basal" 18S level. 
Strains depleted of the essential small nuclear RNA U14 
(snPd28) are also limited for growth by their ability to syn- 
thesize 18S rRNA (Zagorski et al., 1988; Li et al., 1990) as 
are cells depleted of NO/I  by growth of the GAL: :nopl 
strain  on  medium  containing  glucose  (Tollervey  et  al., 
1991). In snR128 or NOPI depleted strains, the precursors 
to 18S rRNA are very rapidly degraded, whereas in the hu- 
man fibrillarin complemented strain the unmethylated 23S 
pre-rRNA accumulates, although no accumulation of meth- 
ylated pre-rRNA is detected. Unmethylated 35S pre-rRNA 
also  accumulates in  the human fibrillarin complemented 
strain. In this mutant, as in strains depleted of NOP1 (Toiler- 
vey et al., 1991), there appear to be two populations of pre- 
rRNA; unmethylated pre-rRNA accumulates, while methyl- 
ated pre-rRNA is processed relatively more efficiently. 
As well as allowing its functional analysis, the cloning of 
The Journal of Cell Biology, Volume 113,  1991  728 human fibrillarin will allow the study of the molecular basis 
of the autoimmune  antigenicity  of this protein in patients 
suffering from scleroderma (Tan, 1989). 
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